Thursday, October 30, 2025 12:29:44 PM
the whole conversation was about becoming a "WS Darling". To do that you need to show "massive revenue". Some of the SP predictions on this board are flat-out absurd......$10-15-20-30. C'mon, the SP is stuck at .25 for godsakes. If the last 10 years has told us anything, it is that the only think that will create a sustainable rising SP is revenue and related earnings. I gave a few examples of what it takes. The Pharma world is the most regulated space and its even more difficult that the tech sector which doesnt have the government in the way. The science behind NWBO is good but I think there is a lasting opinion that NWBO might not be able to capitalize on the technology. Until revenue starts to increase and Management can demonstrate they can take their "ideas" and turn them into folding green/USD's, I dont think NW SP will increase much, even upon MHRA approval. Sorry you might not like my opinion, but I am entitled to it. I do agree on your partnership theory...if BP dumped $500m+ onto NWBO coffers via a partnership it would change a lot of things for NW, including the SP. At this point there are too many "what ifs". "What if" none of this ever happens? Because that a real possibility too, for anyone that has ever dabbled in the highly speculative pre-comm biotech sector. This arena is a literal graveyard of dead companies that retail investors where high on at one time. In this sector, speculation like some of the things talked about on this board have led to lots of investors being overly optimistic, investing vast sums of money, and then subsequently losing all of it after all the hype and over the top speculation never materializes. I tread lightly when it comes to these things. History has my back when it comes to why I feel like this.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
